CROI 2017 Program and Information

Program and Agenda

Poster Sessions • Wednesday Poster P-I3 ART: VIRAL RESPONSE OVER THE LONG TERM Poster Hall - 4 EF 2:30 PM - 4:00 PM 461 VIROLOGICAL RESPONSE TO ANTIRETROVIRAL TREATMENT IN AN EASTERN EUROPEAN COHORT STUDY Radko Avi , Merit Pauskar, Heli Rajasaar, Eveli Kallas, Ene-Ly Jõgeda, Pilleriin Soodla, Irja Lutsar, Kristi Huik, for the Estonian HIV Positive Patients Database Univ of Tartu, Tartu, Estonia 462 DURABILITY OF NNRTI BASED REGIMENS AFTER 7 YEARS OF TREATMENT IN RURAL UGANDA Mastula Nanfuka 1 , Zishan Cui 2 , Stephen Okoboi 1 , Josephine Birungi 1 , Pontiano Kaleebu 3 , Julia Zhu 2 , Samuel Tibengana 1 , David Moore 4 1 The AIDS Support Organization, Kampala, Uganda, 2 BC Cntr for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, 3 Med Rsr Council, Entebbe, Uganda, 4 Univ of British Columbia, Vancouver, British Columbia, Canada 437 PRO140 SINGLE-AGENTMAINTENANCE THERAPY FOR HIV-1 INFECTION: A 2-YEAR UPDATE Jay Lalezari 1 , Kush Dhody 2 , Ula Kowalczyk 1 , Kazem Kazempour 2 , Nader Pourhassan 3 , Paul J. Maddon 4 1 Quest Clinical Rsr, San Francisco, CA, USA, 2 Amarex Clinical Rsr, LLC, Germantown, MD, USA, 3 CytoDyn Inc, Vancouver, WA, USA, 4 Maddon Advisors LLC, Scarsdale, NY, USA 438 INTRAMUSCULAR IBALIZUMAB: PHARMACOKINETICS, SAFETY, AND EFFICACY VS IV ADMINISTRATION Hsi-Hsun Lin 1 , Susan Shin-Jung Lee 2 , Ning-Chi Wang 3 , YingAn Lai 4 , Kuei- Ling Kuo 4 , Steven Weinheimer 5 , Stanley Lewis 5 1 E-Da Hosp, Kaohsiung City, Taiwan, 2 Kaohsiung Veterans General Hosp, Kaohsiung, Taiwan, 3 Tri-Service General Hosp, Taipei City, Taiwan, 4 TaiMed Biologics, Taipei City, Taiwan, 5 TaiMed Biologics USA, Irvine, CA, USA 439 A LONG-ACTING NANOFORMULATED CABOTEGRAVIR PRODRUG FOR IMPROVED ANTIRETROVIRAL THERAPY Tian Zhou , Benson Edagwa, JoEllyn McMillan, Howard E. Gendelman Univ of Nebraska, Omaha, NE, USA 440 ANTIVIRAL ACTIVITY OF EFDA AGAINST NRTI-SENSITIVE AND -RESISTANT STRAINS OF HIV-2 Vincent Wu 1 , Robert Smith 1 , Sara Masoum 1 , Dana Raugi 1 , Selly Ba 2 , Moussa Seydi 2 , Jay Grobler 3 , Geoffrey Gottlieb 1 , for the University of Washington– Dakar HIV-2 Study Group 1 Univ of Washington, Seattle, WA, USA, 2 CHU de Fann, Dakar, Senegal, 3 Merck & Co, West Point, PA, USA

463 LONG-TERMVIRAL SUPPRESSION DURING INITIAL ANTIRETROVIRAL THERAPY INHANOI, VIETNAM

Junko Tanuma 1 , Shoko Matsumoto 1 , Sebastien Haneuze 2 , Cuong Do Duy 3 , Thanh Thuy Pham Thi 3 , Dung T. Nguyen 4 , Kinh V. Nguyen 4 , Shinichi Oka 1 1 Natl Cntr for Global Hlth and Med, Tokyo, Japan, 2 Harvard Univ, Boston, MA, USA, 3 Bach Mai Hosp, Hanoi, Vietnam, 4 Natl Hosp for Trop Diseases, Hanoi, Vietnam

CROI 2017 136